SUPN

Supernus Pharmaceuticals, Inc. SUPN

$46.94 -0.93 (-1.94%)

Neutral · -0.22σ

+ Compare Open in Sniper

Mkt cap $2.8B

P/E —

Day $46.81 – $48.12

52wk $42.45 – $59.68

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

At a glance

Supernus Pharmaceuticals, Inc. is a healthcare company listed in the US.

SUPN last traded at $46.94, down 1.9% on the day; that's in the lower part of its 52-week range ($42.45–$59.68). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $132.11 (fair range $31–$132); today's price leaves a +64% cushion below that estimate. The model's verdict is “Deep value” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.

Deep value +64% margin of safety Accounting: Adequate

Intrinsic (DCF)

$132.11

Fair-value range

$31.27 – $132.11

Margin of safety

+64%

Accounting quality Adequate

✓ More cash than debt
✓ Quick ratio 1.69 (antifragile)
✓ Debt/equity 0.37 (antifragile)
✓ Goodwill 9% of assets (organic growth)

⚠ Receivables growing faster than revenue
⚠ Inventory growing faster than revenue

Price implies ~6% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

SUPN is a $2.8 billion company.

Market cap $2.8B

P/E ttm —

Beta —

52w range $42.45 – $59.68

Avg volume —

Dividend yield —

Sector Healthcare

Next earnings —

52-week range · today's price

$42.45$59.68